Laura K. Schnackenberg Source Confirmed
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
National Center for Toxicological Research
faculty
Research Areas
Links
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
Laura K. Schnackenberg's research program focuses on the toxicological assessment of chemical compounds and the development of advanced methods for studying drug-induced organ toxicities. Her work investigates the mechanisms by which chemicals, including environmental contaminants and pharmaceutical agents, impact cellular function, particularly within the liver and kidneys. She has published research on the toxicity of tire rubber antiozonants and their transformation products in human hepatocytes, as well as the effects of specific drugs like pexidartinib on mitochondrial function and cell death pathways.
Schnackenberg also explores the application of cutting-edge technologies for toxicity testing and biomarker discovery. This includes utilizing organ-on-a-chip platforms, such as the Emulate® Liver-Chip, for co-culturing human primary liver cells to study drug-induced liver injury. Additionally, her research has involved the discovery of proteomic biomarkers for predicting kidney recovery in patients undergoing dialysis and the analysis of serum metabolite profiles to predict outcomes in critically ill patients receiving renal replacement therapy. She has also investigated the prediction of oncology drug-induced cardiotoxicity using induced pluripotent stem cell-derived cardiomyocytes.
Her scholarly contributions are evidenced by 87 publications and 3,499 citations, with an h-index of 34. Schnackenberg maintains an active research group and collaborates with colleagues at the National Center for Toxicological Research, including Katy S Papineau and Lijun Ren, with whom she has co-authored five publications.
Metrics
- h-index: 34
- Publications: 87
- Citations: 3,499
Selected Publications
- Challenges and solutions in measuring commonly used biomarkers for drug-induced liver injury in a liver-on-a-chip platform (2025) DOI
- Toxicity of ubiquitous tire rubber antiozonant N-(1,3-dimethylbutyl)-N′-phenyl-p-phenylenediamine (6PPD) and its transformation product 6PPD-quinone (6PPD-Q) in primary human hepatocytes and liver spheroids (2025) DOI
- Pexidartinib impairs liver mitochondrial functions causing cell death in primary human hepatocytes at clinically relevant concentrations (2025) DOI
- Predicting oncology drug-induced cardiotoxicity with donor-specific iPSC-CMs—a proof-of-concept study with doxorubicin (2024) DOI
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury (2022) DOI
- Serum metabolite profiles predict outcomes in critically ill patients receiving renal replacement therapy (2021) DOI
- Discovery of Novel Proteomic Biomarkers for the Prediction of Kidney Recovery from Dialysis-Dependent AKI Patients (2021) DOI
- MALDI imaging mass spectrometry: an emerging tool in neurology (2021) DOI
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics